Matches in Wikidata for { <http://www.wikidata.org/entity/Q97566897> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q97566897 description "article scientifique publié en 2020" @default.
- Q97566897 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97566897 description "scientific article published on 15 July 2020" @default.
- Q97566897 description "wetenschappelijk artikel" @default.
- Q97566897 description "наукова стаття, опублікована 15 липня 2020" @default.
- Q97566897 name "Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study" @default.
- Q97566897 name "Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study" @default.
- Q97566897 type Item @default.
- Q97566897 label "Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study" @default.
- Q97566897 label "Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study" @default.
- Q97566897 prefLabel "Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study" @default.
- Q97566897 prefLabel "Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study" @default.
- Q97566897 P1433 Q97566897-E67A296D-9C22-4C5F-8D6F-19FBA9324DB0 @default.
- Q97566897 P1476 Q97566897-82F290E5-7C5D-4FCF-A164-63FAE605866A @default.
- Q97566897 P2093 Q97566897-27A75F04-FA85-4BFE-B313-E3FE64E43C04 @default.
- Q97566897 P2093 Q97566897-28B10AD9-8867-4153-A1FE-964019625C7F @default.
- Q97566897 P2093 Q97566897-3217546A-A04F-441E-A1DF-C902F95000B5 @default.
- Q97566897 P2093 Q97566897-40AD0B43-36E4-4647-9165-AFC5B521CA8B @default.
- Q97566897 P2093 Q97566897-57447E21-4D05-4B9D-B970-6C7D68FDEECB @default.
- Q97566897 P2093 Q97566897-5C47DEC0-1AC9-4C01-B8BE-FD9733674BFA @default.
- Q97566897 P2093 Q97566897-8A0C32FC-773D-4227-82FE-DCC22FDDC307 @default.
- Q97566897 P2093 Q97566897-A56C9490-E35F-4213-951E-834A573D19C8 @default.
- Q97566897 P2093 Q97566897-A623B418-C262-41F1-B6FC-14E73E1FF6A3 @default.
- Q97566897 P31 Q97566897-44330E8D-0F8D-4E63-BF2F-92E567DEB1A7 @default.
- Q97566897 P356 Q97566897-91DC0EDB-4919-4B67-AD62-A598F311BDF8 @default.
- Q97566897 P50 Q97566897-0A514C79-BDE5-437A-809A-C3E46E50867B @default.
- Q97566897 P50 Q97566897-65978353-5DEE-43DE-B21D-6576CCCC12DA @default.
- Q97566897 P50 Q97566897-D6EF9197-1DEC-421A-A044-81DBA3C0A45A @default.
- Q97566897 P577 Q97566897-8F07B4B6-DC2A-4887-AEAE-0A53C56CE139 @default.
- Q97566897 P698 Q97566897-63BCB261-710B-45BC-BA47-2B41D3BD7A98 @default.
- Q97566897 P921 Q97566897-12873AD1-3404-42F9-90FB-789B85116BB4 @default.
- Q97566897 P921 Q97566897-DA64EE4F-F2D8-48A9-8750-14EA42F29360 @default.
- Q97566897 P921 Q97566897-EFFC04F8-66EB-408C-BB3F-10AA43B64BA2 @default.
- Q97566897 P356 1078-0432.CCR-20-1170 @default.
- Q97566897 P698 32669371 @default.
- Q97566897 P1433 Q332253 @default.
- Q97566897 P1476 "Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study" @default.
- Q97566897 P2093 "Anthony Kong" @default.
- Q97566897 P2093 "Beatriz Castelo Fernandez" @default.
- Q97566897 P2093 "Burak Gumuscu" @default.
- Q97566897 P2093 "Danny Rischin" @default.
- Q97566897 P2093 "Hoi-Shen Radcliffe" @default.
- Q97566897 P2093 "Jason Chesney" @default.
- Q97566897 P2093 "Jonathan Cheng" @default.
- Q97566897 P2093 "Kevin J Harrington" @default.
- Q97566897 P2093 "Wendy Snyder" @default.
- Q97566897 P31 Q13442814 @default.
- Q97566897 P356 "10.1158/1078-0432.CCR-20-1170" @default.
- Q97566897 P50 Q38641744 @default.
- Q97566897 P50 Q92127474 @default.
- Q97566897 P50 Q97566892 @default.
- Q97566897 P577 "2020-07-15T00:00:00Z" @default.
- Q97566897 P698 "32669371" @default.
- Q97566897 P921 Q13896859 @default.
- Q97566897 P921 Q18348812 @default.
- Q97566897 P921 Q18975728 @default.